Literature DB >> 15488883

Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction.

Ilka Ott1, Werner Koch, Nicolas von Beckerath, Rene de Waha, Anna Malawaniec, Julinda Mehilli, Albert Schömig, Adnan Kastrati.   

Abstract

Tissue factor (TF), the main initiator of the extrinsic coagulation cascade is expressed in atherosclerotic lesions and contributes to coronary thrombus formation in myocardial infarction (MI). Circulating TF reflects intravascular TF activation but also adds to prothrombotic activation. Because the G allele of the TF promotor polymorphism -603 A/G is associated with monocytic mRNA expression we evaluated its association with myocardial infarction, based on a recessive deleterious effect assumption. Patients with MI (MI; n=793) and age and sex matched control subjects without coronary artery disease (C; n=340) undergoing coronary angiography were included. In patients with MI, the -603 G (MI: 76%, C: 70%) allele was prevalent compared to the control group (P=-0.04). Multivariate analysis revealed an odds ratio of 1.44 (confidence interval 1.07-1.93). Carriage of the -603 G allele is associated with an increased risk for myocardial infarction. Because higher plasma TF concentrations are found in -603 G carriers enhanced TF expression may be the mechanism underlying this association.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488883     DOI: 10.1016/j.atherosclerosis.2004.07.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

Review 1.  Genetic susceptibility to thrombosis.

Authors:  James P Luyendyk; Rachel E Tilley; Nigel Mackman
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

2.  Influence of tissue factor polymorphisms (603A>G and 5466A>G) on plasma tissue factor levels and their impact on deep vein thrombosis risk in young Indian population.

Authors:  Kamal Kishor; Amit Sharma; Kanwaljeet Singh; Ravi Ranjan; Hareram Pandey; Ravi Kumar; Vineet Kumar Kamal; Pravas Mishra; Manoranjan Mahapatra; Renu Saxena
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

3.  Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes.

Authors:  Trine B Opstad; Alf Age Pettersen; Thomas Weiss; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2010-05-05

4.  Molecular genetics of myocardial infarction.

Authors:  Yoshiji Yamada; Sahoko Ichihara; Tamotsu Nishida
Journal:  Genomic Med       Date:  2008-08-14

5.  Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction.

Authors:  Joshua W Knowles; Huijan Wang; Haruka Itakura; Audrey Southwick; Richard M Myers; Carlos Iribarren; Stephen P Fortmann; Alan S Go; Thomas Quertermous; Mark A Hlatky
Journal:  Am Heart J       Date:  2007-12       Impact factor: 4.749

6.  Lemierre's syndrome and genetic polymorphisms: a case report.

Authors:  Jean-Michel Constantin; Jean-Paul Mira; Renaud Guerin; Sophie Cayot-Constantin; Olivier Lesens; Florence Gourdon; Jean-Pierre Romaszko; Philippe Linval; Henri Laurichesse; Jean-Etienne Bazin
Journal:  BMC Infect Dis       Date:  2006-07-17       Impact factor: 3.090

7.  Novel hydroxybutyl chitosan nanoparticles for siRNA delivery targeting tissue factor inhibits proliferation and induces apoptosis in human vascular smooth muscle cells.

Authors:  Kang Wan; Jian Li; Dan Li; Junhua Ge; Yunlong Wang; Xuexun Li; Yongfang Guo; Junjie Guo; Min Leng; Pan Wang; Yi An
Journal:  Mol Med Rep       Date:  2015-10-21       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.